Home › Opioid Overdose › NCT07044466
Social Functioning in Opioid Use Disorder
Real-world Assessment of Social Functioning During OUD Treatment: Integrating Reports From Patients and Their Concerned Significant Others
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Any sex or gender; any race or ethnicity; aged 18 years or older * Patient participants must meet DSM-5 diagnostic criteria for current (i.e., past 12 months) OUD (assessed via the Quick Structured Clinical Interview for DSM-5; Quick SCID) * Patient participants must be on medication for opioid use disorder (MOUD), as prescribed by their provider, for no more than 12 weeks prior to study initiation * Patient participants must be in treatment at a clinic in South Carolina * Concurrent substance use disorders (e.g., alcohol, cannabis) for the patient participant are acceptable, provided opioids are the patient participant's primary substance of choice * Patient participants must identify a CSO participant who consents to participation in the study as well Exclusion Criteria: * Moderate-to-severe opioid withdrawal as defined by a score of ≥21 on the Subjective Opioid Withdrawal Scale * Meeting DSM-5 criteria for a history of or current psychotic or bipolar disorders * Current suicidal or homicidal ideation and intent; participants who present a serious suicide risk are likely to require hospitalization during the study and they will be referred clinically * CSO participants meeting DSM-5 criteria for opioid use disorder or any other substance use disorder, excepting tobacco use disorder, mild cannabis use disorder, and mild alcohol use disorder * Severe interpersonal violence in the past six months between the patient and the CSO, as defined by an adapted version of the Conflict Tactics Scaled Revised (CTS-2) * Pregnancy for patient participants * Prisoners, institutional individuals, and children will not be recruited for this study.
About the study
Problems with social functioning are core to opioid use disorder (OUD), though specific, modifiable social functioning targets and how they relate to OUD treatment outcomes are poorly understood. This study will utilize both data from both patients with OUD and their concerned significant other (CSO) to examine associations between specific social functioning metrics and OUD treatment outcomes. Findings from this study will inform future precision-medicine approaches for people with OUD, a population in significant need of enhanced treatment approaches to combat opioid morbidity and mortality.
What is being tested
- CBT4CBT-Buprenorphine (behavioral)
Sponsor: Medical University of South Carolina · Participants: 230 · Started: Aug 13, 2026
Contact the study team
- Amber Anderson, BA · Phone: 843-876-3115
- Kevin Branson, MA · Phone: 843-876-3115
Official record on ClinicalTrials.gov — NCT07044466
Locations in the U.S.
| South Carolina | Medical University of South Carolina, Charleston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.